Member Info for EarlofAim

This week Company on USA tour to various Cities

take a look

https://twitter.com/EquityTrader888/status/1772554770705723893?t=UNE7aV9JeM21RLLNAjmJRA&s=19

Davey50

be pragmatic..... Monoclonal antibodies market size is over $200B

just 1% of this is worth over $2b US Dollars, which means a staggering upside for FAB......

yet you do not perceive this Knowledge or can't comprehend or process this Potential in your Brian.

let this sink in!!!!

Https://www.biospace.com/article/releases/cancer-monoclonal-antibodies-market-size-estimated-to-reach-usd-410-95-billion-by-2032/

Davy50

look at this before making silly comments.......

$200b isn't a figure I plucked out of thin air!!!

Https://www.biospace.com/article/releases/cancer-monoclonal-antibodies-market-size-estimated-to-reach-usd-410-95-billion-by-2032/

I'm surprised Company don't know this yet or Haven't Rns the Monoclonal Antibodies Market Size yet.......

Google "What is the market size for Monoclonal Antibodies"

it's over $200 billion dollar industry and rising to ¥500billion in the next few years.

only 1% of the market share is worth a look at staggering £2Billion

yes two Billion dollars.

market is missing this

NCI

national trust cancer Institute in the USA

collaboration since November 2023, since then no update yet, so most likely will be an update soon

News coming soon on this collaboration update......

OptiMAL® collaboration agreement

Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces that it has signed a collaboration agreement (the "Agreement") with the National Cancer Institute ("NCI") for the use of OptiMAL® in the discovery of novel antibodies against targets selected by NCI.

Under the terms of the Agreement, Fusion will provide access to the OptiMAL® technology to NCI for deployment against an agreed number of targets, being primarily cancer targets, over a period of up to two years, in order to develop potential therapeutic antibodies against the selected targets. The parties will work together to ensure successful validation of the OptiMAL® technology and jointly publish any results from the collaboration. The validation will be run at NCI's laboratories by their staff and antibodies identified pursuant to the Agreement would be retained by NCI.

Funds managers are looking to invest in Bio Tech

https://www.thisismoney.co.uk/money/diyinvesting/article-13227289/Im-fund-manager-biotech-investor-Ailsa-Craig-thinks-rate-cuts-spark-rebound.html

Billions worth

Monoclonal Antibodies Market: The global monoclonal antibodies market size accounted for USD 201.63 billion in 2022 and is projected to hit around USD 634.64 billion by 2032, poised to grow at a CAGR of 12.2% over the forecast period from 2023 to 2032

Https://www.biospace.com/article/releases/cancer-monoclonal-antibodies-market-size-estimated-to-reach-usd-410-95-billion-by-2032/

Https://fusionantibodies.com/optimal-a-novel-library-and-mammalian-display-platform-for-antibody-discovery/?utm_source=sales&utm_medium=email&utm_campaign=OptiMAL&utm_content=OptiMAL+Video

Fusion-antibiotics-plc

just needs 1% share of the $200 Billion market share for the Monoclonal Antibodies 😳

Mcap £3m is ridiculously cheap for that sort of potential.

Mcap should go to £15m at least on the potential value

then when Contracts starts to come Sp can shoot up exponentially

Has anyone seen this

Monoclonal Antibodies Market: The global monoclonal antibodies market size accounted for USD 201.63 billion in 2022 and is projected to hit around USD 634.64 billion by 2032, poised to grow at a CAGR of 12.2% over the forecast period from 2023 to 2032

https://www.biospace.com/article/releases/cancer-monoclonal-antibodies-market-size-estimated-to-reach-usd-410-95-billion-by-2032/

Fusion Antibodies FAB just needs 1% of that $200 billion dollar market, that's is unbelievable amount of money

$200B at 1% is$2 Billion

wow!!!!

just need 1% market share and FAB would be worth billion Mcap company!

Has anyone seen this

Monoclonal Antibodies Market: The global monoclonal antibodies market size accounted for USD 201.63 billion in 2022 and is projected to hit around USD 634.64 billion by 2032, poised to grow at a CAGR of 12.2% over the forecast period from 2023 to 2032

https://www.biospace.com/article/releases/cancer-monoclonal-antibodies-market-size-estimated-to-reach-usd-410-95-billion-by-2032/

Could be buys because part of midday onwards It was NT to buy,

hmm... could mms facilitated these 3X 250k buys?

upwards and onwards....

Time for Fusion Antibodies FAB to get some big contracts from the USA.

With £500billion Monoclonal Antibodies Market Size Worth, won't be hard for FAB to get £100m contract.

just matter of time

Monoclonal Antibodies Market Size Worth USD 572.62 Billion in 2032 | Emergen Research

Emergen Research

https://finance.yahoo.com/news/monoclonal-antibodies-market-size-worth-131700950.html

any wonder FAB was 60p not long ago

Anyone having difficulty buying now?

Mms not allowing me to buy anymore

cmon mms make a market please.

Petroinvestor

you trying too hard mate......

look at my tip on FDBK back in February when Sp was 60p

today it's over 140p

Earl did it again......

click on my name for more ideas......

next one is a reporter biggie and it's in Bio tech sector

can't name here, click on my name